A recent multicentre transcriptomic study demonstrated that hepatic GDF-15 expression was positively associated with NAFLD severity and GDF-15 expression was significantly higher in patients with advanced liver fibrosis [10]. The gene discussed is GDF15; the disease is metabolic dysfunction-associated steatotic liver disease.